Fifty leading HIV prevention experts met in Chapel Hill, North Carolina (May 13-14, 2009) to advance the development of HIV-incidence assays-tests that are used to identify the number of new HIV cases in a population within a given time period. Scientists and other experts proposed various ways to make better use of current assays and to facilitate development of new HIV incidence assays, and the best ways to determine the global demand for these assays. The meeting was convened by Family Health International (FHI), with support from the Bill & Melinda Gates Foundation, the World Health Organization (WHO), the HIV Prevention Trials Network (HPTN) and the Center for HIV/AIDS Vaccine Immunology (CHAVI). A full report of the meeting proceedings is available at:
http://www.fhi.org/en/HIVAIDS/pub/meeting_reports/HIV_inc_assays.htm



To manage subscriptions/passwords, or view archives, go to http://listserv.yorku.ca/archives/click4hp.html . [log in to unmask] is run in collaboration with Health Nexus: http://www.healthnexus.ca/index_eng.php